Detection of Mutant BRAF Alleles in the Plasma of Patients With Metastatic Melanoma

Journal of Molecular Diagnostics - United States
doi 10.2353/jmoldx.2007.060135
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2015English

PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic Melanoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Plasma Markers for Identifying Patients With Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2011English

Uncommon BRAF Mutations Associated With Durable Response to Immunotherapy in Patients With Metastatic Melanoma

Case Reports in Oncological Medicine
Oncology
2017English

Evaluation of KRAS, NRAS and BRAF Mutations Detection in Plasma Using an Automated System for Patients With Metastatic Colorectal Cancer

PLoS ONE
Multidisciplinary
2020English

Encorafenib/Binimetinib for the Treatment of BRAF-mutant Advanced, Unresectable, or Metastatic Melanoma: Design, Development, and Potential Place in Therapy

OncoTargets and Therapy
OncologyPharmacology
2018English

Accelerated BRAF Mutation Analysis Using a Fully Automated PCR Platform Improves the Management of Patients With Metastatic Melanoma

Oncotarget
Oncology
2018English

Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy